HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 296/4/R1140    most recent 90822.2008v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mortensen, S. P. Articles by Hellsten, Y. Search for Related Content PubMed PubMed Citation Articles by Mortensen, S. P. Articles by Hellsten, Y.

EXERCISE AND RESPIRATORY PHYSIOLOGY

ATP-induced vasodilation and purinergic receptors in the human leg: roles of nitric oxide, prostaglandins, and adenosine

¹The Copenhagen Muscle Research Centre, Rigshospitalet, Copenhagen; ³Department of Biology, University of Copenhagen, Copenhagen; ⁴Institute of Exercise and Sports Sciences, University of Copenhagen, Copenhagen, Denmark; and ²Centre for Sports Medicine and Human Performance, Brunel University, London, United Kingdom

Submitted 9 October 2008 ; accepted in final form 29 December 2008

Plasma ATP is thought to contribute to the local regulation of skeletal muscle blood flow. Intravascular ATP infusion can induce profound limb muscle vasodilatation, but the purinergic receptors and downstream signals involved in this response remain unclear. This study investigated: 1) the role of nitric oxide (NO), prostaglandins, and adenosine as mediators of ATP-induced limb vasodilation and 2) the expression and distribution of purinergic P₂ receptors in human skeletal muscle. Systemic and leg hemodynamics were measured before and during 5–7 min of femoral intra-arterial infusion of ATP [0.45–2.45 µmol/min] in 19 healthy male subjects with and without coinfusion of N^G-monomethyl-L-arginine (L-NMMA; NO formation inhibitor; 12.3 ± 0.3 (SE) mg/min), indomethacin (INDO; prostaglandin formation blocker; 613 ± 12 µg/min), and/or theophylline (adenosine receptor blocker; 400 ± 26 mg). During control conditions, ATP infusion increased leg blood flow (LBF) from baseline conditions by 1.82 ± 0.14 l/min. When ATP was coinfused with either L-NMMA, INDO, or L-NMMA + INDO combined, the increase in LBF was reduced by 14 ± 6, 15 ± 9, and 39 ± 8%, respectively (all P < 0.05), and was associated with a parallel lowering in leg vascular conductance and cardiac output and a compensatory increase in leg O₂ extraction. Infusion of theophylline did not alter the ATP-induced leg hyperemia or systemic variables. Real-time PCR analysis of the mRNA content from the vastus lateralis muscle of eight subjects showed the highest expression of P_2Y2 receptors of the 10 investigated P₂ receptor subtypes. Immunohistochemistry showed that P_2Y2 receptors were located in the endothelium of microvessels and smooth muscle cells, whereas P_2X1 receptors were located in the endothelium and the sacrolemma. Collectively, these results indicate that NO and prostaglandins, but not adenosine, play a role in ATP-induced vasodilation in human skeletal muscle. The expression and localization of the nucleotide selective P_2Y2 and P_2X1 receptors suggest that these receptors may mediate ATP-induced vasodilation in skeletal muscle.

skeletal muscle; adenosine 5'-triphosphate; purinergic receptors; nitric oxide; prostaglandins

This article has been cited by other articles:

				D. P. Casey, B. D. Madery, T. L. Pike, J. H. Eisenach, N. M. Dietz, M. J. Joyner, and B. W. Wilkins Adenosine receptor antagonist and augmented vasodilation during hypoxic exercise J Appl Physiol, October 1, 2009; 107(4): 1128 - 1137. [Abstract] [Full Text] [PDF]

				S. P. Mortensen, M. Nyberg, P. Thaning, B. Saltin, and Y. Hellsten Adenosine Contributes to Blood Flow Regulation in the Exercising Human Leg by Increasing Prostaglandin and Nitric Oxide Formation Hypertension, June 1, 2009; 53(6): 993 - 999. [Abstract] [Full Text] [PDF]